StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
120
This month
3
This year
21
Publishing Date
2024 - 03 - 11
2
2024 - 02 - 27
2
2023 - 10 - 27
3
2023 - 10 - 06
2
2023 - 05 - 11
1
2023 - 05 - 01
1
2023 - 04 - 26
2
2023 - 03 - 30
1
2023 - 03 - 13
1
2023 - 02 - 13
1
2023 - 01 - 23
2
2022 - 12 - 13
2
2022 - 10 - 27
2
2022 - 10 - 06
2
2022 - 09 - 28
1
2022 - 09 - 27
1
2022 - 09 - 23
1
2022 - 09 - 08
2
2022 - 08 - 12
1
2022 - 08 - 04
1
2022 - 08 - 03
2
2022 - 07 - 29
1
2022 - 07 - 21
1
2022 - 07 - 19
2
2022 - 07 - 15
1
2022 - 07 - 13
2
2022 - 07 - 12
1
2022 - 07 - 06
1
2022 - 07 - 05
1
2022 - 06 - 30
1
2022 - 06 - 29
1
2022 - 06 - 17
1
2022 - 06 - 15
1
2022 - 06 - 06
2
2022 - 06 - 01
1
2022 - 05 - 20
2
2022 - 05 - 10
1
2022 - 04 - 28
1
2022 - 04 - 08
2
2022 - 03 - 31
1
2022 - 03 - 29
1
2022 - 02 - 25
1
2022 - 02 - 23
1
2022 - 02 - 21
1
2022 - 02 - 04
1
2022 - 02 - 03
1
2022 - 02 - 01
1
2021 - 12 - 15
1
2021 - 12 - 09
1
2021 - 11 - 16
1
2021 - 11 - 15
1
2021 - 11 - 12
1
2021 - 11 - 08
1
2021 - 11 - 04
1
2021 - 10 - 28
1
2021 - 10 - 25
1
2021 - 10 - 22
2
2021 - 10 - 15
1
2021 - 10 - 13
1
2021 - 10 - 08
1
Sector
Finance
2
Health technology
120
Manufacturing
2
Mining, quarrying, and oil and gas extraction
1
Tags
Acquisition
80
Alliances
71
America
64
Antibody
48
Approval
63
Approved
41
Biopharma
81
Biotech
49
Biotechnology
105
Business
80
Cancer
165
Children
61
Clinical-trials-phase-ii
42
Clinical-trials-phase-iii
67
Collaboration
80
Companies
59
Conference
48
Covid
43
Covid-19
75
Deal
50
Disease
130
Drug
173
Dupixent
105
Earnings
72
Europe
72
Events
54
Expected
44
Fda
204
Fda-approvals
43
Financial
163
Genetown
59
Global
356
Growing
50
Growth
280
Health
67
Market
711
Money
58
N/a
2233
News
98
People
161
Pharm-country
42
Pharma
145
Pharmaceutical
120
Positive
79
Potential
59
Reach
50
Regulatory
55
Report
307
Research
233
Results
291
Sanofi
199
Spac
46
Study
86
Therapeutics
320
Therapy
79
Treatment
229
Trial
120
Update
91
Vaccine
163
Year
61
Entities
Abbott laboratories
12
Absci corp
1
Ac immune sa
2
Acer therapeutics inc.
1
Advaxis, inc.
1
Alnylam pharmaceuticals, inc.
2
Angle plc
1
Biogen inc.
1
Cytodyn inc.
1
Eli lilly and company
1
Evotec se
1
Gilead sciences, inc.
1
Innate pharma s.a.
14
Innate pharma sa
14
Invivo therapeutics holdings corp.
1
Johnson & johnson
23
Kamada ltd.
1
Karuna therapeutics, inc.
1
Lannett co inc
1
Lexicon pharmaceuticals, inc.
1
Merck & company, inc.
1
Moderna, inc.
1
Morgan stanley
2
Novo nordisk a/s
7
Nurix therapeutics, inc.
1
Ocular therapeutix, inc.
1
Oncocyte corporation
1
Pds biotechnology corporation
2
Perrigo company
13
Provention bio, inc.
1
Regeneron pharmaceuticals, inc.
2
Sanofi
120
Teva pharmaceutical industries ltd
2
Veracyte, inc.
2
Xortx therapeutics inc.
1
Symbols
ABBV
5
ABT
16
ACER
5
ADAP
8
ADXN
12
AERI
6
AGNPF
6
ALIM
5
ALPMF
5
ALPMY
5
AMPH
5
AMYT
5
AUTL
6
AYTU
7
AZN
5
BGNE
6
BMY
13
BNTX
5
BXRX
5
CALT
10
EVO
12
EVOTF
13
EYPT
7
FNCTF
14
GILD
10
GLSI
6
HGEN
11
HROW
10
IKT
6
IMRN
8
IMUX
8
IPHA
15
IPHYF
14
JNJ
98
KALV
7
KPRX
11
KPTI
9
KRTX
12
LLY
24
MBRX
6
MOR
8
MPSYF
6
MRK
34
MS
18
NBY
6
NKTR
6
NRXP
6
NVO
12
OPT
7
PFE
17
PRGO
14
RMTI
8
SAGE
9
SHPH
7
SKYE
9
SNY
143
SNYNF
120
TAK
17
WST
8
ZOM
13
Exchanges
Amex
1
Nasdaq
120
Nyse
37
Crawled Date
2024 - 03 - 11
2
2024 - 02 - 27
2
2023 - 10 - 27
3
2023 - 10 - 06
2
2023 - 05 - 11
1
2023 - 05 - 01
1
2023 - 04 - 26
2
2023 - 03 - 30
1
2023 - 03 - 13
1
2023 - 02 - 13
1
2023 - 01 - 23
2
2022 - 12 - 13
2
2022 - 10 - 27
2
2022 - 10 - 06
2
2022 - 09 - 28
1
2022 - 09 - 27
1
2022 - 09 - 23
1
2022 - 09 - 08
2
2022 - 08 - 12
1
2022 - 08 - 04
1
2022 - 08 - 03
2
2022 - 07 - 29
1
2022 - 07 - 21
1
2022 - 07 - 19
2
2022 - 07 - 15
1
2022 - 07 - 13
2
2022 - 07 - 12
1
2022 - 07 - 06
1
2022 - 07 - 05
1
2022 - 06 - 30
1
2022 - 06 - 29
1
2022 - 06 - 17
1
2022 - 06 - 15
1
2022 - 06 - 06
2
2022 - 06 - 01
1
2022 - 05 - 20
2
2022 - 05 - 10
1
2022 - 04 - 28
1
2022 - 04 - 08
2
2022 - 03 - 31
1
2022 - 03 - 29
1
2022 - 02 - 25
1
2022 - 02 - 23
1
2022 - 02 - 21
1
2022 - 02 - 04
1
2022 - 02 - 03
1
2022 - 02 - 01
1
2021 - 12 - 15
1
2021 - 12 - 09
1
2021 - 11 - 16
1
2021 - 11 - 15
1
2021 - 11 - 12
1
2021 - 11 - 08
1
2021 - 11 - 04
1
2021 - 10 - 28
1
2021 - 10 - 25
1
2021 - 10 - 22
2
2021 - 10 - 15
1
2021 - 10 - 13
1
2021 - 10 - 08
1
Crawled Time
05:00
2
06:00
4
07:00
5
08:00
5
09:00
4
10:00
2
11:00
9
12:00
5
12:30
1
13:00
5
13:20
4
13:30
5
14:00
13
14:15
1
14:20
2
14:30
2
15:00
21
15:20
2
15:30
4
16:00
9
17:00
7
18:00
2
19:00
3
21:00
1
22:00
1
23:00
1
Source
www.biospace.com
120
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Pharmaceutical
symbols :
SNYNF
save search
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published:
2024-04-05
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.54%
|
O:
-1.77%
H:
0.0%
C:
-1.81%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-2.07%
|
O:
-0.22%
H:
0.8%
C:
0.06%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.81%
|
O:
-1.84%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-2.57%
|
O:
-0.37%
H:
1.42%
C:
1.37%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.72%
|
O:
-3.44%
H:
0.0%
C:
0.0%
fda
for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published:
2024-04-03
(Crawled : 13:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.66%
|
O:
-0.29%
H:
1.34%
C:
-0.64%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.23%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.23%
|
O:
0.11%
H:
0.37%
C:
-0.77%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.94%
|
O:
0.69%
H:
0.0%
C:
0.0%
fda
drug
schizophrenia
AstraZeneca Kicks Off April With New PNH Approval
Published:
2024-04-02
(Crawled : 13:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.08%
|
O:
-1.09%
H:
0.13%
C:
-1.39%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.26%
|
O:
-0.77%
H:
0.8%
C:
0.74%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.29%
|
O:
-0.18%
H:
0.47%
C:
0.12%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.05%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
approval
astrazeneca
XORTX Announces New Clinical Advisory Board Member - March 27, 2024
Published:
2024-03-27
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
XRTX
|
$3.5
-3.05%
-3.14%
12K
|
Mining, Quarrying, and Oil and ...
|
1.84%
|
O:
0.0%
H:
0.0%
C:
-5.79%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.89%
|
O:
1.06%
H:
0.0%
C:
0.0%
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published:
2024-03-22
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.65%
|
O:
-1.58%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-2.47%
|
O:
0.35%
H:
0.99%
C:
-1.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.9%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.21%
|
O:
-0.43%
H:
0.41%
C:
-0.85%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.44%
|
O:
1.47%
H:
0.23%
C:
-0.19%
fda
hypertension
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published:
2024-03-21
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.16%
|
O:
0.3%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-2.4%
|
O:
-4.51%
H:
4.25%
C:
0.96%
pharma
business
year
update
financial
results
Incyte Gets Phase II Win, Targets Blockbuster Dupixent in Skin Disease
Published:
2024-03-11
(Crawled : 16:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.66%
|
O:
0.57%
H:
0.0%
C:
0.0%
disease
dupixent
skin
FDA Rejects Viatris, Mapi’s Long-Acting Multiple Sclerosis Injection
Published:
2024-03-11
(Crawled : 14:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.66%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
sclerosis
injection
FDA Decisions: Multiple Issues Cited in Rejection of Minerva’s Schizophrenia Hopeful
Published:
2024-02-29
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.89%
|
O:
-1.6%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
16.62%
|
O:
0.11%
H:
0.98%
C:
-0.68%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.18%
|
O:
0.56%
H:
0.12%
C:
-0.38%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.64%
|
O:
0.22%
H:
0.1%
C:
-1.4%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.63%
|
O:
-0.11%
H:
0.0%
C:
0.0%
fda
schizophrenia
GSK, Sanofi Exit Nigerian Market Amid Lingering Foreign Exchange Crisis
Published:
2024-02-28
(Crawled : 06:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.24%
|
O:
-0.63%
H:
0.0%
C:
0.0%
sanofi
market
Denali Secures $500M in Financing, Focuses on Large Molecule Biotherapeutics
Published:
2024-02-27
(Crawled : 17:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.14%
|
O:
-0.94%
H:
0.0%
C:
0.0%
FDA Decisions: Allecra Succeeds Where Competitors Failed; Another Humira Copycat
Published:
2024-02-27
(Crawled : 15:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.26%
|
O:
-10.69%
H:
0.0%
C:
-4.98%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.55%
|
O:
-1.07%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-9.61%
|
O:
-0.44%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.14%
|
O:
-0.94%
H:
0.0%
C:
0.0%
fda
humira
TL1A Inhibitors Could Usher in New Era for IBD Treatment
Published:
2024-02-26
(Crawled : 05:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.68%
|
O:
-0.82%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.3%
|
O:
0.89%
H:
0.0%
C:
0.0%
treatment
Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published:
2024-02-21
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.49%
|
O:
1.7%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.32%
|
O:
-0.57%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-5.79%
|
O:
-2.32%
H:
0.0%
C:
0.0%
pharma
conference
Sanofi, Denali ALS Candidate Flops in Mid-Stage Trial
Published:
2024-02-19
(Crawled : 13:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
candidate
als
trial
FDA Decisions: Sanofi/Regeneron's Dupixent Racks Up Another Pediatric Indication
Published:
2024-02-02
(Crawled : 15:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.58%
|
O:
-0.53%
H:
1.28%
C:
0.53%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.43%
|
O:
-0.15%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-6.3%
|
O:
-0.57%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.46%
|
O:
-0.93%
H:
0.0%
C:
0.0%
fda
dupixent
J&J, Merck CEOs Agree to Testify Before Senate Panel and Dodge Subpoena
Published:
2024-01-29
(Crawled : 15:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.77%
|
O:
-0.75%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.68%
|
O:
0.12%
H:
0.0%
C:
0.0%
merck
Sanders Confident of Senate Panel’s Support for Subpoenaing J&J, Merck CEOs
Published:
2024-01-26
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-6.6%
|
O:
1.8%
H:
0.0%
C:
-1.82%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.03%
|
O:
0.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.21%
|
O:
0.5%
H:
0.0%
C:
0.0%
merck
Senator Sanders Warns J&J, Merck CEOs Could Be Subpoenaed on Drug Pricing
Published:
2024-01-19
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-9.9%
|
O:
-0.5%
H:
0.0%
C:
-0.83%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.52%
|
O:
0.67%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.76%
|
O:
-1.23%
H:
0.0%
C:
0.0%
drug
merck
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published:
2024-01-12
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-11.92%
|
O:
0.71%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.54%
|
O:
0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-12.54%
|
O:
0.0%
H:
0.36%
C:
0.36%
pharma
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.